GlassScriptPhysician profile
Peter A Schneider
NPI 1720189640
$4,816,324.65
in general payments reported to CMS, 2019-2025
32 companies · $300K in 2025
The $300K reported for 2025 was more than what 99% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $1.1M · 2020: $727K · 2021: $703K · 2022: $705K · 2023: $667K · 2024: $631K · 2025: $300K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1.4M · Travel and Lodging: $122K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $95K · Food and Beverage: $15K · Honoraria: $12K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,353,523.45 |
| Travel and Lodging | $122,002.87 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $95,000.00 |
| Food and Beverage | $14,981.89 |
| Honoraria | $11,550.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $900.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $2,382,696.21 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Surmodics, INC. | $1,475,369.00 | 2019-2025 | Sundance, Pounce Thrombectomy System, Transcend |
| Medtronic Vascular, INC. | $178,829.71 | 2019-2020 | |
| Boston Scientific Corporation | $148,797.01 | 2019-2025 | Enroute Transcarotid Neuroprotection System, General - Therapies, Ranger |
| Cardiovascular Systems INC. | $130,734.42 | 2019-2022 | |
| Cagent Vascular INC | $115,221.26 | 2019-2025 | Serrantor |
| Medtronic, INC. | $107,472.80 | 2021-2025 | In.Pact Admiral, Venaseal, Hawkone |
| Intact Vascular, INC. | $74,051.92 | 2019 | |
| Elucid Bioimaging INC | $53,593.45 | 2021-2022 | |
| Philips North America LLC | $52,600.34 | 2019-2024 | (9520) Igt Devices Undivided |
| Endologix LLC | $37,552.07 | 2022-2025 | Endocross Device, Torus Stent Graft System |
| Limflow INC. | $12,678.29 | 2023 | Limflow System |
| Abbott Laboratories | $9,611.47 | 2019-2025 | Xact |
| Inari Medical, INC. | $8,178.42 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cordis US Corp. | $6,377.56 | 2024-2025 | Mynx Control Venous, Selution Slrpta, Selution Slr Pta |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $6,180.28 | 2019-2021 | |
| Biotronik INC. | $4,775.00 | 2023-2025 | |
| Novo Nordisk As | $3,750.00 | 2021 | |
| W. L. Gore & Associates, INC. | $2,753.48 | 2019-2025 | Product In Development, C3 Delivery System, Gore Tag Thoracic Endoprosthesis |
| Stryker Corporation | $1,811.50 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Microvention, INC. | $1,500.00 | 2019-2020 | |
| Cook Medical LLC | $404.50 | 2019-2022 | |
| Inspiremd LTD | $332.79 | 2023-2025 | Cguard, Cguard Prime Carotid Stent System |
| Penumbra, INC. | $279.77 | 2021-2025 | Indigo System, Penumbra System |
| Viz.Ai, INC. | $279.09 | 2021-2022 | |
| Shockwave Medical, INC | $266.16 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biosense Webster, INC. | $116.55 | 2023 | Nuvision Ice Catheter |
| Merit Medical Systems INC | $64.81 | 2025 | |
| Angiodynamics, INC. | $24.87 | 2021 | |
| Vesper Medical | $21.92 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$186,975.65 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$64,524.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Schneider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.